Company intelligence / Profile preview

SimBioSys

Chicago, Illinois, United Statessimbiosys.com ↗
Ownership
Private
Employees
~36
Development stage
Commercial
01

Overview

SimBioSys has demonstrated over 92% accuracy in predicting response to therapy in early breast cancer through independent clinical validation studies at leading institutions. Its TumorScope/TumorSight Viz platforms are used at top U.S. cancer centers and have received FDA clearance as a diagnostic aid for preoperative planning in breast conservation surgery. The company collaborates with more than twenty major academic medical centers and continues expanding its technology into new indications.

Therapeutic areas
Oncology
Modalities
Non-pharmacological therapy (digital twin modeling)Device (FDA-cleared software for imaging analysis)Software platform (AI-driven simulation)Clinical decision support tool
Industry
Medical Imaging
02

Partnerships

Mayo ClinicUCLAUniversity of Chicagocollaborations with over twenty leading U.S. academic medical centersNVIDIA Startup Program participant

Beyond the preview

Go deeper on SimBioSys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SimBioSys.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call